Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer | Future Oncology
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Slowing the PSA | prost8blog
Goserelin - Wikipedia
Golexin 3.6mg - AMW GmbH - Arzneimittelwerk Warngau - english Version
Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy | Nature Reviews Urology
Advances in the Management of Metastatic Breast Cancer; Hormonal Therapy and Targeted Agents (Slides with Transcript)
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
Endocrinology of Prostate Cancer - ppt download
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology
Mechanism of action of luteinizing-hormone-releasing hormone analogues.... | Download Scientific Diagram
Oncology
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists | Prostate Cancer and Prostatic Diseases
Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons - Fertility and Sterility
Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application - Cancer Treatment Reviews
Will GnRH antagonists improve prostate cancer treatment?: Trends in Endocrinology & Metabolism
Evolution of breast cancer treatments: current options and quality-of-life considerations - European Journal of Oncology Nursing
Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer - Van Poppel - 2020 - International Journal of Urology - Wiley Online Library
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy | NEJM
Targeting of Steroid Hormone Receptor Function in Breast and Prostate Cancer | SpringerLink
Frontiers | Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women | Oncology
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review)
Pituitary and hypothalamic hormones - Medical Pharmacology and Therapeutics, 4e
